IN THE NEWS

Respiratory

Ritedose Pharmaceuticals Continues Tradition of Giving Back – Increases its Annual Donation to Unprecedented Amount of 1 Million Doses of Respiratory Medications to Dispensary of Hope for Low-income and Chronically lll Patients

COLUMBIA, S.C., August 12, 2024 – Ritedose Pharmaceuticals, a division of The Ritedose Corporation (Ritedose), the leading contract development and manufacturing organization (CDMO) specializing in sterile Blow Fill Seal (BFS) production, announces today that it will donate 1 Million (1M)…
READ MORE
smiling volunteers performing verious chores at a food bank

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand for Ophthalmic and Respiratory Medications

COLUMBIA, S.C. June 20, 2024 – The Ritedose Corporation (Ritedose), the leading contract development and manufacturing organization (CDMO) specializing in sterile Blow Fill Seal (BFS) production, announces a significant expansion of its production capabilities to meet the demand for ophthalmic…
READ MORE
interior of large warehouse with forklifts in foreground and text overlay: we are expanding

Ritedose Reaches Milestone with Asset Purchase

COLUMBIA, S.C.—The Ritedose Corporation, LLC now offers the most complete nebulized inhalation drug portfolio in the industry with the purchase of the Arformoterol Tartrate asset from PAI Pharma of Greenville, S.C. (more…)
READ MORE
panoramic photo featuring Ritedose's main campus with text overlay: Ritedose becomes the largest generic drug maker of its kind

Novo Holdings to acquire Ritedose

 COPENHAGEN, Denmark, Jan. 4, 2022 /PRNewswire/ – Founded in 1995 and headquartered in Columbia, S.C., The Ritedose Corporation (“Ritedose”) is a leading sterile pharmaceutical manufacturer, specialising in the use of blow-fill-seal (BFS) technology. Ritedose provides outsourced development and manufacturing of…
READ MORE
angled view of a yellow wall with white letterforms and a backlit logo mark with text overlay: Ritedose joins Novo Holdings
FEATURED NEWS
RECEIVE THE LATEST NEWS

Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.

Please enter a valid email address.
TAGS CLOUD

Tags

Albuterol ApiJect Arformoterol Tartrate Benedict College BFS Capital Project Careers CDMO Charitable Community COVID-19 Dispensary of Hope Donation Education Expansion Formoterol Fumarate Generics Give Back Harvest Hope Health Science Homeless No More of Columbia Inhalation Injectables Innovation Liquid Manufacturing Medication Newberry College Novo Group Novo Holdings Novo Nordisk Novozymes Opthalmic Oral PAI Pharma Pharmaceuticals Respiratory RISE Ritedose Park Solutions STEM SuredoseRx United Way Vaccines Workforce Development

Accessibility